JP6116908B2 - 心房細動の治療 - Google Patents

心房細動の治療 Download PDF

Info

Publication number
JP6116908B2
JP6116908B2 JP2012539071A JP2012539071A JP6116908B2 JP 6116908 B2 JP6116908 B2 JP 6116908B2 JP 2012539071 A JP2012539071 A JP 2012539071A JP 2012539071 A JP2012539071 A JP 2012539071A JP 6116908 B2 JP6116908 B2 JP 6116908B2
Authority
JP
Japan
Prior art keywords
administration
sulfate
active agent
composition
sarcardin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012539071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511473A5 (https=
JP2013511473A (ja
Inventor
ティー. エリオット ゲリー
ティー. エリオット ゲリー
バイ ドングル
バイ ドングル
ワン イッピン
ワン イッピン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Original Assignee
Shanghai Institute of Materia Medica of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS filed Critical Shanghai Institute of Materia Medica of CAS
Publication of JP2013511473A publication Critical patent/JP2013511473A/ja
Publication of JP2013511473A5 publication Critical patent/JP2013511473A5/ja
Application granted granted Critical
Publication of JP6116908B2 publication Critical patent/JP6116908B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
JP2012539071A 2009-11-17 2010-11-16 心房細動の治療 Active JP6116908B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26192509P 2009-11-17 2009-11-17
US61/261,925 2009-11-17
PCT/US2010/056857 WO2011062906A2 (en) 2009-11-17 2010-11-16 Treatment of atrial fibrillation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015171604A Division JP2016028054A (ja) 2009-11-17 2015-09-01 心房細動の治療

Publications (3)

Publication Number Publication Date
JP2013511473A JP2013511473A (ja) 2013-04-04
JP2013511473A5 JP2013511473A5 (https=) 2017-02-02
JP6116908B2 true JP6116908B2 (ja) 2017-04-19

Family

ID=44060290

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012539071A Active JP6116908B2 (ja) 2009-11-17 2010-11-16 心房細動の治療
JP2015171604A Pending JP2016028054A (ja) 2009-11-17 2015-09-01 心房細動の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015171604A Pending JP2016028054A (ja) 2009-11-17 2015-09-01 心房細動の治療

Country Status (10)

Country Link
US (1) US8541464B2 (https=)
EP (2) EP2501381B1 (https=)
JP (2) JP6116908B2 (https=)
CN (3) CN104324024A (https=)
DK (2) DK2501381T3 (https=)
ES (2) ES2644818T3 (https=)
HU (2) HUE034007T2 (https=)
PL (2) PL2501381T3 (https=)
RS (1) RS63699B1 (https=)
WO (1) WO2011062906A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2501381B1 (en) * 2009-11-17 2017-07-26 Huya Bioscience International LLC Treatment of atrial fibrillation
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts
SG2013035662A (en) 2013-05-08 2014-12-30 Menicon Singapore Pte Ltd Systems and methods for printing on a contact lens
CN113453677A (zh) * 2018-12-13 2021-09-28 沪亚生物国际有限责任公司 用于治疗急性心房颤动的舒卡定施用
SG11202108160YA (en) * 2019-01-29 2021-08-30 Huya Bioscience International Llc Sulcardine salts
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
IL298907A (en) * 2020-06-12 2023-02-01 Huyabio Int Llc Administering sulcardin for the treatment of acute atrial fibrillation
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
EP2501381B1 (en) * 2009-11-17 2017-07-26 Huya Bioscience International LLC Treatment of atrial fibrillation
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts

Also Published As

Publication number Publication date
CN105362264A (zh) 2016-03-02
WO2011062906A9 (en) 2011-10-06
EP3311810A1 (en) 2018-04-25
ES2644818T3 (es) 2017-11-30
DK2501381T3 (da) 2017-11-06
WO2011062906A8 (en) 2012-02-09
JP2016028054A (ja) 2016-02-25
US8541464B2 (en) 2013-09-24
ES2929185T3 (es) 2022-11-25
CN104324024A (zh) 2015-02-04
EP2501381A2 (en) 2012-09-26
RS63699B1 (sr) 2022-11-30
PL3311810T3 (pl) 2022-12-05
EP2501381A4 (en) 2013-06-12
CN102665714A (zh) 2012-09-12
US20120309810A1 (en) 2012-12-06
HUE034007T2 (en) 2018-01-29
PL2501381T3 (pl) 2018-02-28
DK3311810T3 (da) 2022-10-24
WO2011062906A2 (en) 2011-05-26
EP3311810B1 (en) 2022-07-27
HUE060876T2 (hu) 2023-04-28
EP2501381B1 (en) 2017-07-26
JP2013511473A (ja) 2013-04-04
HK1254495A1 (en) 2019-07-19

Similar Documents

Publication Publication Date Title
JP6116908B2 (ja) 心房細動の治療
JP6173391B2 (ja) サルカルディン及びその塩の緩速点滴
JP2013511473A5 (https=)
US8188140B2 (en) Uses of ion channel modulating compounds
JP2013511472A5 (https=)
CA2524034A1 (en) Uses of ion channel modulating compounds
RU2358732C2 (ru) Жидкие фармацевтические композиции, содержащие производные 3,7-диазабицикло(3,3,1)нонана, для лечения антиаритмических реакций
HK1254495B (en) Use of sulcardine for the treatment of atrial fibrillation
KR20230024347A (ko) 급성 심방 세동의 치료를 위한 설카르딘 투여
HK1176859B (en) Treatment of atrial fibrillation
HK1176859A (en) Treatment of atrial fibrillation
EP1868598B1 (en) A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human
JPS61172820A (ja) カルシウム拮抗剤
HK1176858B (en) Slow infusion of sulcardine and its salts
EA045624B1 (ru) Введение сулькардина для лечения острой фибрилляции предсердий

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20131015

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140213

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20140213

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140422

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150228

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150821

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20151013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151106

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20151013

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20161219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170322

R150 Certificate of patent or registration of utility model

Ref document number: 6116908

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250